Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease

NeuroImage

Volumn 60, Issue 1, 2012, Pages 700-716

  Vounou, Maria ^a   Janousova, Eva ^a   Wolz, Robin ^a   Stein, Jason L ^b   Thompson, Paul M ^b   Rueckert, Daniel ^a   Montana, Giovanni ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; APOE GENE; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DISCRIMINANT ANALYSIS; DISEASE COURSE; FEMALE; GENE; GENE MAPPING; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; HUMAN; IMAGE ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; PENALIZED LINEAR DISCRIMINANT ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPARSE REDUCED RANK REGRESSION; STATISTICAL MODEL; TOMM40 GENE; VOXEL BASED MORPHOMETRY;

ALGORITHMS; ALZHEIMER DISEASE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NEUROIMAGING; PHENOTYPE;

EID: 84856108049     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.12.029     Document Type: Article

References (103)

1. Alzheimer's disease facts and figures. Alzheimer's Dement. 2011, 7(2):208-244. Alzheimer's Association.
2. Atiya M., Hyman B., Albert M., Killiany R. Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review. Alzheimer Dis. Assoc. Disord. 2003, 17(3):177-195.
3. Barabash A., Marcos A., Ancin I., Vazquez-Alvarez B., de Ugarte C., Gil P., Fernández C., Encinas M., López-Ibor J., Cabranes J. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease. Neurobiol. Aging 2009, 30(8):1254-1264.
4. Batmanghelich N., Taskar B., Davatzikos C. A general and unifying framework for feature construction, in image-based pattern classification. Information Processing in Medical Imaging 2009, 423-434. Springer.
5. Baum A., Akula N., Cabanero M., Cardona I., Corona W., Klemens B., Schulze T., Cichon S., Rietschel M., Nöthen M., et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol. Psychiatry 2008, 13(2):197-207.
6. Bertram L., McQueen M., Mullin K., Blacker D., Tanzi R. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39(1):17-23.
7. Bertram L., Lill C., Tanzi R. The genetics of Alzheimer disease: back to the future. Neuron 2010, 68(2):270-281.
8. Bhalla K., Phillips H., Crawford J., McKenzie O., Mulley J., Eyre H., Gardner A., Kremmidiotis G., Callen D. The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene. J. Hum. Genet. 2004, 49(6):308-311.
9. Booth S., Bowman C., Baumgartner R., Sorensen G., Robertson C., Coulthart M., Phillipson C., Somorjai R. Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J. Gen. Virol. 2004, 85:3459-3471.
10. Boyes R.G., Rueckert D., Aljabar P., Whitwell J., Schott J.M., Hill D.L., Fox N.C. Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integral. NeuroImage 2006, 32(1):159-169.
11. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82(4):239-259.
12. Braak E., Griffing K., Arai K., Bohl J., Bratzke H., Braak H. Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249(9):14-22.
13. Braskie M., Ringman J., Thompson P. Neuroimaging measures as endophenotypes in Alzheimer's disease. Int. J. Alzheimers Dis. 2011, 2011:490140.
14. Breiman L. Stacked regressions. Mach. Learn. 1996, 24(1):49-64.
15. Breiman L., Friedman J. Predicting multivariate responses in multiple linear regression. J. R. Stat. Soc. B Methodol. 1997, 3-54.
16. Brockington A., Heath P., Holden H., Kasher P., Bender F., Claes F., Lambrechts D., Sendtner M., Carmeliet P., Shaw P. Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFδ/δ mouse model of amyotrophic lateral sclerosis. BMC Genomics 2010, 11(1):203.
17. Brown M., Bridgman P. Myosin function in nervous and sensory systems. J. Neurobiol. 2004, 58(1):118-130.
18. Cathcart H., Huang R., Lanham I., Corder E., Poduslo S. Cystatin C as a risk factor for Alzheimer disease. Neurology 2005, 64(4):755-757.
19. Chang K., Min K. Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: implications for Down syndrome. Proc. Natl. Acad. Sci. 2009, 106(40):17117-17122.
20. Chen K., Langbaum J., Fleisher A., Ayutyanont N., Reschke C., Lee W., Liu X., et al. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. NeuroImage 2010, 51(2):654-664.
21. Chiang M., Barysheva M., McMahon K., de Zubicaray G., Johnson K., Martin N., Toga A., Wright M., Thompson P. Hierarchical clustering of the genetic connectivity matrix reveals the network topology of gene action on brain microstructure: an N=531 twin study. Biomedical Imaging: From Nano to Macro, 2011 IEEE International Symposium on 2011, 832-835. IEEE.
22. Chun H., Keleş S. Sparse partial least squares regression for simultaneous dimension reduction and variable selection. J. R. Stat. Soc. B Stat. Methodol. 2010, 72(1):3-25.
23. Corder E., Saunders A., Strittmatter W., Schmechel D., Gaskell P., Small G., Roses A., Haines J., Pericak-Vance M. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261(5123):921-923.
24. Csernansky J., Wang L., Swank J., Miller J., Gado M., McKeel D., Miller M., Morris J. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. NeuroImage 2005, 25(3):783-792.
25. Cuingnet R., Gerardin E., Tessieras J., Auzias G., Lehéricy S., Habert M., Chupin M., Benali H., Colliot O. Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison of ten methods using the ADNI database. NeuroImage 2011, 56(2):766-781.
26. Davatzikos C., Xu F., An Y., Fan Y., Resnick S. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 2009, 132(8):2026-2035.
27. DeKosky S., Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science 2003, 302(5646):830-834.
28. Duda R., Hart P., Stork D. Pattern Classification, Volume 2 2001, John Wiley & Sons.
29. Eyler L., Prom-Wormley E., Fennema-Notestine C., Panizzon M., Neale M., Jernigan T., Fischl B., Franz C., Lyons M., Stevens A., et al. Genetic patterns of correlation among subcortical volumes in humans: results from a magnetic resonance imaging twin study. Hum. Brain Mapp. 2011, 32:641-653.
30. Fan J., Li R. Variable selection via nonconcave penalized likelihood and its oracle properties. J. Am. Stat. Assoc. 2001, 96(456):1348-1360.
31. Fan Y., Batmanghelich N., Clark C.M., Davatzikos C. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. NeuroImage 2008, 39(4):1731-1743.
32. Fan Y., Resnick S., Wu X., Davatzikos C. Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. NeuroImage 2008, 41(2):277-285.
33. Ferreira M., Purcell S. A multivariate test of association. Bioinformatics 2009, 25(1):132-133.
34. Filippini N., Rao A., Wetten S., Gibson R.A., Borrie M., Guzman D., Kertesz A., Loy-English I., Williams J., Nichols T., Whitcher B., Matthews P.M. Anatomically-distinct genetic associations of APOE ε4 allele load with regional cortical atrophy in Alzheimer's disease. NeuroImage 2009, 44(3):724-728.
35. Fisher R., et al. The use of multiple measurements in taxonomic problems. Ann. Eugenics 1936, 7:179-188.
36. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
37. Friedman J., Hastie T., Tibshirani R. A note on the group lasso and a sparse group lasso 2010, arXiv:1001.0736.
38. Grossman I., Lutz M., Crenshaw D., Saunders A., Burns D., Roses A. Alzheimer's disease: diagnostics, prognostics and the road to prevention. EPMA J. 2010, 1-11.
39. Hamshere M., Green E., Jones I., Jones L., Moskvina V., Kirov G., Grozeva D., Nikolov I., Vukcevic D., Caesar S., et al. Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br. J. Psychiatry 2009, 195(1):23-29.
40. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M., Pahwa J., Moskvina V., Dowzell K., Williams A., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41(10):1088-1093.
41. Hua X., Lee S., Yanovsky I., Leow A., Chou Y., Ho A., Gutman B., Toga A., Jack C., Bernstein M., et al. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. NeuroImage 2009, 48(4):668-681.
42. Hunter D., Lange K. A tutorial on MM algorithms. Am. Stat. 2004, 58(1):30-37.
43. Izenman A. Reduced-rank regression for the multivariate linear model. J. Multivar. Anal. 1975, 5(2):248-264.
44. Jack C.R., Bernstein M.A., Fox N.C., Thompson P., Alexander G., Harvey D., Borowski B., Britson P.J., Whitwell J.L., et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J. Magn. Reson. Imaging 2008, 27(4):685-691.
45. Jovicich J., Czanner S., Greve D., Haley E., van der Kouwe A., Gollub R., Kennedy D., Schmitt F., Brown G., MacFall J., Fischl B., Dale A. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. NeuroImage 2006, 30(2):436-443.
46. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38(suppl 1):D355.
47. Kim J., Basak J., Holtzman D. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009, 63(3):287-303.
48. Klöppel S., Stonnington C.M., Chu C., Draganski B., Scahill R.I., Rohrer J.D., Fox N.C., Jack C.R., Ashburner J., Frackowiak R.S.J. Automatic classification of MR scans in Alzheimer's disease. Brain 2008, 131(3):681-689.
49. Kohannim O., Hua X., Hibar D., Lee S., Chou Y., Toga A., Jack C., Weiner M., Thompson P. Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol. Aging 2010, 31(8):1429-1442.
50. Kohannim O., Hibar D., Stein J., Jahanshad N., Jack C., Weiner M., Toga A., Thompson P. Boosting power to detect genetic associations in imaging using multi-locus, genome-wide scans and ridge regression. Biomedical Imaging: From Nano to Macro, 2011 IEEE International Symposium on 2011, 1855-1859. IEEE.
51. Lambert J., Grenier-Boley B., Chouraki V., Heath S., Zelenika D., Fievet N., Hannequin D., Pasquier F., Hanon O., Brice A., et al. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. J. Alzheimers Dis. 2010, 20(4):1107-1118.
52. Le Cao K., Rossouw D., Robert-Granie C., Besse P. A sparse PLS for variable selection when integrating Omics data. Stat. Appl. Genet. Mol. Biol. 2008, 7(1):35.
53. Leow A., Yanovsky I., Parikshak N., Hua X., Lee S., Toga A., Jack C., Bernstein M., Britson P., Gunter J., et al. Alzheimer's Disease Neuroimaging Initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. NeuroImage 2009, 45(3):645-655.
54. Li Y., Wang Y., Wu G., Shi F., Zhou L., Lin W., Shen D. Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features. Neurobiol. Aging 2012, 33(2):427.e15-427.e30. (Electronic publication ahead of print).
55. Lindahl P., Abrahamson M., Björk I. Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. Biochem. J. 1992, 281:49-55.
56. Lounici K., Pontil M., Tsybakov A., Van De Geer S. Oracle inequalities and optimal inference under group sparsity 2010, arXiv:1007.1771v3.
57. Martin C., Duvall J., Ilkin Y., Simon J., Arreaza M., Wilkes K., Alvarez-Retuerto A., Whichello A., Powell C., Rao K., et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144(7):869-876.
58. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J. A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). NeuroImage 1995, 2(2):89-101.
59. McFarland M., Ellis C., Markey S., Nussbaum R. Proteomics analysis identifies phosphorylation-dependent α-synuclein protein interactions. Mol. Cell. Proteomics 2008, 7(11):2123-2137.
60. Meinshausen N., Bühlmann P. Stability selection. J. R. Stat. Soc. B Stat. Methodol. 2010, 72(4):417-473.
61. Micheva K., Kay B., McPherson P. Synaptojanin forms two separate complexes in the nerve terminal. J. Biol. Chem. 1997, 272(43):27239-27245.
62. Misra C., Fan Y., Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. NeuroImage 2009, 44(4):1415-1422.
63. Monastero R., Camarda C., Cefalu A., Caldarella R., Camarda L., Noto D., Averna M., Camarda R. No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. J. Alzheimers Dis. 2005, 7(4):291-296.
64. Mühleisen T., Basmanav F., Forstner A., Mattheisen M., Priebe L., Herms S., Breuer R., Moebus S., Nenadic I., Sauer H., et al. Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients. Schizophr. Res. 2011, 127(1-3):35-40.
65. Parkhomenko E., Tritchler D., Beyene J. Sparse canonical correlation analysis with application to genomic data integration. Stat. Appl. Genet. Mol. Biol. 2009, 8(1):1.
66. Petersen R. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256(3):183-194.
67. Potkin S., Guffanti G., Lakatos A., Turner J., Kruggel F., Fallon J., Saykin A., Orro A., Lupoli S., Salvi E., et al. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 2009, 4(8):e6501.
68. Ravetti M., Rosso O., Berretta R., Moscato P. Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One 2010, 5(4):e10153.
69. Reichelt, A., Rodgers, R., and Clapcote, S. (in press). The role of neurexins in schizophrenia and autistic spectrum disorder. Neuropharmacology.
70. Reinsel G., Velu R. Multivariate Reduced-Rank Regression 1998, Springer, New York.
71. Roses A., Lutz M., Amrine-Madsen H., Saunders A., Crenshaw D., Sundseth S., Huentelman M., Welsh-Bohmer K., Reiman E. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J. 2009, 10(5):375-384.
72. Rueckert D., Sonoda L.I., Hayes C., Hill D.L.G., Leach M.O., Hawkes D.J. Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans. Med. Imaging 1999, 18(8):712-721.
73. Saykin A., Shen L., Foroud T., Potkin S., Swaminathan S., Kim S., Risacher S., Nho K., Huentelman M., Craig D., et al. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans. Alzheimers Dement. 2010, 6(3):265-273.
74. Shen L., Kim S., Risacher S., Nho K., Swaminathan S., West J., Foroud T., Pankratz N., Moore J., Sloan C., et al. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort. NeuroImage 2010, 53(3):1051-1063.
75. Silver, M., Montana, G., in press. Fast identification of biological pathways associated with a quantitative trait using group lasso with overlaps. Statistical Applications in Genetics and Molecular Biology.
76. Skup M., Zhu H., Wang Y., Giovanello K., Lin J., Shen D. Sex differences in grey matter atrophy patterns among AD and AMCI patients: results from ADNI. NeuroImage 2011, 56:890-906.
77. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17(1):87-97.
78. Smola A., Schölkopf B. A tutorial on support vector regression. Stat. Comput. 2004, 14(3):199-222.
79. Stein J.L., Hua X., Lee S., Ho A.J., Leow A.D., Toga A.W., Saykin A.J., Shen L., Foroud T., Pankratz N., Huentelman M.J., Craig D.W., Gerber J.D., Allen A.N., Corneveaux J.J., Dechairo B.M., Potkin S.G., Weiner M.W., Thompson P. Voxelwise genome-wide association study (vGWAS). NeuroImage 2010, 53(3):1160-1174.
80. Stephanie, C. (2008). Genes associated with Alzheimer's disease - Hltdip. US Patent App. 12/117,845.
81. Stopkova P., Saito T., Papolos D., Vevera J., Paclt I., Zukov I., Bersson Y., Margolis B., Strous R., Lachman H. Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol. Psychiatry 2004, 55(10):981-988.
82. Stopkova P., Vevera J., Paclt I., Zukov I., Lachman H. Analysis of SYNJ1, a candidate gene for 21q22 linked bipolar disorder: a replication study. Psychiatry Res. 2004, 127(1-2):157-161.
83. Stranger B., Stahl E., Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2011, 187(2):367-383.
84. Thompson P., Hayashi K., De Zubicaray G., Janke A., Rose S., Semple J., Herman D., Hong M., Dittmer S., Doddrell D., et al. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 2003, 23(3):994-1005.
85. Tibshirani R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. B 1996, 58(1):267-288.
86. Tsolakidou A., Czibere L., Putz B., Trumbach D., Panhuysen M., Deussing J., Wurst W., Sillaber I., Landgraf R., Holsboer F., et al. Gene expression profiling in the stress control brain region hypothalamic paraventricular nucleus reveals a novel gene network including amyloid beta precursor protein. BMC Genomics 2010, 11(1):546.
87. Twine N., Janitz K., Wilkins M., Janitz M. Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease. PLoS One 2011, 6(1):e16266.
88. Vemuri P., Gunter J.L., Senjem M.L., Whitwell J.L., Kantarci K., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. NeuroImage 2008, 39(3):1186-1197.
89. Vemuri P., Wiste H., Weigand S., Shaw L., Trojanowski J., Weiner M., Knopman D., Petersen R., Jack C. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 2009, 73(4):294-301.
90. Vounou M., Nichols T., Montana G. Discovering genetic associations with high-dimensional neuroimaging phenotypes: a sparse reduced-rank regression approach. NeuroImage 2010, 53(3):1147-1159.
91. Waaijenborg S., de Witt Hamer V., Philip C., Zwinderman A. Quantifying the association between gene expressions and DNA-markers by penalized canonical correlation analysis. Stat. Appl. Genet. Mol. Biol. 2008, 7(1):3.
92. Walhovd K., Fjell A., Brewer J., McEvoy L., Fennema-Notestine C., Hagler D., Jennings R., Karow D., Dale A. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. Am. J. Neuroradiol. 2010, 31(2):347-354.
93. Wang X., Su B., Zheng L., Perry G., Smith M., Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J. Neurochem. 2009, 109:153-159.
94. Witten D., Tibshirani R. Penalized classification using Fisher's linear discriminant. Journal of the Royal Statistical Society: Series B. 2011, 73(5):753-772.
95. Witten D., Tibshirani R., Hastie T. A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. Biostatistics 2009, 10(3):515-534.
96. Wolz R., Aljabar P., Hajnal J., Hammers A., Rueckert D. LEAP: Learning Embeddings for Atlas Propagation. NeuroImage 2010, 49(2):1316-1325.
97. Wolz R., Heckemann R., Aljabar P., Hajnal J., Hammers A., Lötjönen J., Rueckert D. Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI. NeuroImage 2010, 52(1):109-118.
98. Yuan M., Lin Y. Model selection and estimation in regression with grouped variables. J. R. Stat. Soc. B 2006, 68(1):49-67.
99. Zhang C. Nearly unbiased variable selection under minimax concave penalty. Ann. Stat. 2010, 38(2):894-942.
100. Zhang D., Wang Y., Zhou L., Yuan H., Shen D. Multimodal classification of Alzheimer's disease and mild cognitive impairment. NeuroImage 2011, 55:856-867.
101. Zondervan K., Cardon L. The complex interplay among factors that influence allelic association. Nat. Rev. Genet. 2004, 5(2):89-100.
102. Zucconi A., Dente L., Santonico E., Castagnoli L., Cesareni G. Selection of ligands by panning of domain libraries displayed on phage lambda reveals new potential partners of synaptojanin 1. J. Mol. Biol. 2001, 307(5):1329-1339.
103. Zuo L., Van Dyck C., Luo X., Kranzler H., Yang B., Gelernter J. Variation at APOE and STH loci and Alzheimer's disease. Behav. Brain Funct. 2006, 2:13.